James L. L. Tullis - 25 Jun 2021 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Director
Signature
/s/ James L. L. Tullis
Issuer symbol
XGN
Transactions as of
25 Jun 2021
Net transactions value
-$382,110
Form type
4
Filing time
29 Jun 2021, 17:10:27 UTC
Previous filing
21 Jun 2021
Next filing
23 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Sale $140,503 -8,763 -0.56% $16.03 1,546,909 25 Jun 2021 See footnote F1, F2, F5
transaction XGN Common Stock Sale $162,696 -10,858 -0.7% $14.98 1,536,051 28 Jun 2021 See footnote F1, F3, F5
transaction XGN Common Stock Sale $78,910 -5,379 -0.35% $14.67 1,530,672 29 Jun 2021 See footnote F1, F4, F5
holding XGN Common Stock 21,348 25 Jun 2021 Direct
holding XGN Common Stock 1,431 25 Jun 2021 By Spouse
holding XGN Common Stock 4,537 25 Jun 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.74 to $16.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.55 to $15.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $15.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II.